date:Feb 11, 2019
escription drugs at every point in the distribution chain. Using new innovations, we believe we can improve the overall security of our closed system and improve our ability to prevent the introduction of illegitimate products, better detect the introduction of illegitimate products, and enable stakeholders and the FDA to respond more rapidly when such products are found, said FDA Commissioner Scott Gottlieb, M.D. We recognize that tracking and tracing products is critical to industrys ability t